ScholarIQanswers from OpenAlex & ORCID
Aron Goldhirsch
ResearcherPublications, citations & collaboration network
Aron Goldhirsch is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Aron Goldhirsch have?
ScholarIQindexed works
Aron Goldhirsch has 756 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Aron Goldhirsch have?
ScholarIQcitation count
Aron Goldhirsch has 72,618 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Aron Goldhirsch?
ScholarIQh-index
Aron Goldhirsch has an h-index of 122 in OpenAlex.
What is the i10-index of Aron Goldhirsch?
ScholarIQi10-index
Aron Goldhirsch has an i10-index of 421 in OpenAlex.
What is the OpenAlex record for Aron Goldhirsch?
ScholarIQopenalex
The OpenAlex for Aron Goldhirsch is on the source record.
What are the most-cited papers on Aron Goldhirsch?
ScholarIQmost cited works
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Martine Piccart, Marion Procter, Brian Leyland‐Jones, Aron Goldhirsch, Michael Untch, Ian Smith, Luca Gianni, José Baselga, Richard H. Bell, Christian Jackisch, David Cameron, Mitch Dowsett, Carlos H. Barrios, Günther Steger, Chiun‐Sheng Huang, Michael Andersson, Moshe Inbar, Mikhail Lichinitser, István Láng, Ulrike Nitz, Hiroji Iwata, Christoph Thomssen, Caroline Lohrisch, Thomas Suter, Josef Rüschoff, Tamás Sütö, Victoria Greatorex, Carol Ward, Carolyn Straehle, Eleanor McFadden, Mirko Dolci, Richard D. Gelber
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
Aron Goldhirsch, Eric P. Winer, Alan S. Coates, Richard D. Gelber, Martine Piccart, Beat Thürlimann, Hans-Jörg Senn, Kathy S. Albain, Fabrice André, Jonas Bergh, Hervé Bonnefoi, Denisse Bretel-Morales, Harold J. Burstein, Fátima Cardoso, Monica Castiglione‐Gertsch, Alan S. Coates, Marco Colleoni, Alberto Costa, Giuseppe Curigliano, Nancy E. Davidson, Angelo Di Leo, Bent Ejlertsen, John Forbes, Richard D. Gelber, Michael Gnant, Aron Goldhirsch, Pamela J. Goodwin, Paul E. Goss, Jay R. Harris, Daniel F. Hayes, Clifford A. Hudis, James N. Ingle, Jacek Jassem, Zefei Jiang, Per Karlsson, Sibylle Loibl, Monica Morrow, Moïse Namer, C. Kent Osborne, Ann H. Partridge, Frédérique Penault‐Llorca, Charles M. Perou, Martine Piccart, Kathleen I. Pritchard, Emiel J. Rutgers, Felix Sedlmayer, Semiglazov Vf, Zhi‐Ming Shao, Ian Smith, Beat Thürlimann, Masakazu Toi, Andrew Tutt, Michael Untch, Giuseppe Viale, Toru Watanabe, Nicholas Wilcken, Eric P. Winer, William C. Wood
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
Alan S. Coates, Eric P. Winer, Aron Goldhirsch, A. Goldhirsch, R.D. Gelber, M. Gnant, M. Piccart-Gebhart, B. Thürlimann, H.-J. Senn, Fabrice André, José Baselga, Jonas Bergh, Hervé Bonnefoi, Harold Burstein, Fatima Cardoso, Monica Castiglione‐Gertsch, Coates As, Marco Colleoni, Giuseppe Curigliano, Nancy E. Davidson, Angelo Di Leo, Bent Ejlertsen, John Forbes, Galimberti, Richard D. Gelber, Michael Gnant, Aron Goldhirsch, Aron Goldhirsch, Pamela Goodwin, N Harbeck, D. F. Hayes, Jens Huober, Clifford A. Hudis, James N. Ingle, J Jassem, Zefei Jiang, P Karlsson, Monica Morrow, R ORECCHIA, C. Kent Osborne, Ann H. Partridge, Lorena de la Peña, Martine J. Piccart-Gebhart, Kathleen I. Pritchard, E Rutgers, Felix Sedlmayer, Vladimir Semiglazov, Zhi‐Ming Shao, Ian Smith, Beat Thürlimann, Toi M, Gϋnter von Minckwitz, Giuseppe Viale, von Minckwitz G, Toru Watanabe, Timothy Whelan, Eric P. Winer, Binghe Xu
2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial
Ian Smith, Marion Procter, Richard D. Gelber, Sébastien Guillaume, A. Feyereislova, Mitch Dowsett, Aron Goldhirsch, Michael Untch, Gabriella Mariani, José Baselga, Manfred Kaufmann, David Cameron, Richard H. Bell, Jonas Bergh, Robert L. Coleman, Andrew Wardley, Nadia Harbeck, R.I. Lopez, Peter Mallmann, Karen A. Gelmon, Nicholas Wilcken, Erik Wist, Pedro Sánchez‐Rovira, Martine Piccart
Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis
Fabio Conforti, Laura Pala, Vincenzo Bagnardi, Tommaso De Pas, Marco Martinetti, Giuseppe Viale, Richard D. Gelber, Aron Goldhirsch